Janssen Infectious Diseases Diagnostics Bvba

Janssen Infectious Diseases Diagnostics Bvba is a company in Beerse, Belgium that has taken part in 6 EU-funded projects since 2008, receiving €811k in EU funding.

EU funding received€811k
EU projects6
As coordinator0
Running now0
First EU project2008
Latest project2016
CountryBelgium
EU registration (PIC)997391055
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Janssen Infectious Diseases Diagnostics Bvba's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€811k · 5 projects
  • Horizon 2020€0 · 1 project

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • ND4IDPartner

    New Diagnostics for Infectious Diseases: “ND4ID”

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

  • PREPAREPartner

    Platform foR European Preparedness Against (Re-)emerging Epidemics

    FP7 (2007 to 2013) · 2014–2021 · Project on CORDIS ↗

    €188ktheir share
  • EUVIRNAPartner

    European Training Network on (+)RNA Virus Replication and Antiviral Drug Development

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €420ktheir share
  • CHAARMPartner

    Combined Highly Active Anti-retroviral Microbicides

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €50ktheir share
  • CHAINPartner

    Collaborative HIV and Anti-HIV Drug Resistance Network

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

    €80ktheir share
  • THINCPartner

    TARGETING HIV INTEGRATION CO-FACTORS, TARGETING CELLULAR PROTEINS DURING NUCLEAR IMPORT OR INTEGRATION OF HIV

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €73ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • RNA
  • RNA viruses
  • antibiotic resistance
  • antivirals
  • coronaviruses
  • drug discovery
  • drug resistance
  • epidemiology
  • infectious diseases
  • multidrug resistance
  • pandemics
  • proteomics
  • public health

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime